MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in Vivo

Molecular Endocrinology

Volumn 27, Issue 1, 2013, Pages 92-105

  Ansari, Khairul I ^a   Kasiri, Sahba ^a   Hussain, Imran ^a   Morris Bobzean, Samara A ^a   Perrotti, Linda I ^a   Mandal, Subhrangsu S ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN RECEPTORS SCAVENGER RECEPTOR CLASS B TYPE I; MESSENGER RNA; METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN 1; MIXED LINEAGE LEUKEMIA PROTEIN 2; RNA POLYMERASE II; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN RESPONSIVE ELEMENT; GENE OVEREXPRESSION; GENE SILENCING; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROIDOGENESIS;

ANIMALS; CHOLESTEROL; DNA-BINDING PROTEINS; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HEP G2 CELLS; HUMANS; LUCIFERASES, RENILLA; MALE; MICE; MICE, NUDE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BINDING; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTION INITIATION, GENETIC;

MUS;

EID: 84871763737     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1147     Document Type: Article

References (58)

1. Brown MS, Goldstein JL 1983 Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest 72:743-747
2. Grummer RR, Carroll DJ 1988 A review of lipoprotein cholesterol metabolism: importance to ovarian function. J Anim Sci 66:3160-3173
3. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA 2003 Accelerated degradation of HMG CoA reductase mediatedby binding of insig-1 to its sterol-sensing domain. Mol Cell 11:25-33
4. Osono Y, Woollett LA, Herz J, Dietschy JM 1995 Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 95:1124-1132
5. Williams DL, Wong JS, Hamilton RL 2002 SR-BI is required for microvillar channel formation and the localization of HDL particles to the surface of adrenocortical cells in vivo. J Lipid Res 43:544-549
6. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K 1996 SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 222:246-250
7. Krieger M 1999 Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 68:523-558
8. Matsui M, Sakurai F, Elbashir S, Foster DJ, Manoharan M, Corey DR 2010 Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem Biol 17:1344-1355
9. Jian B, dela Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH 1998 Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospho-lipid acceptors. J Biol Chem 273:5599-5606
10. Nieland TJ, Penman M, Dori L, Krieger M, Kirchhausen T 2002 Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci USA 99:15422-15427
11. Silver DL, Jiang XC, Arai T, Bruce C, Tall AR 2000 Receptors and lipid transfer proteins in HDL metabolism. Ann NY Acad Sci 902: 103-111; discussion 111-112
12. Ueda Y, Gong E, Royer L, Cooper PN, Francone OL, Rubin EM 2000 Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 275: 20368-20373
13. Nilsson S, Gustafsson JA 2002 Estrogen receptor action. Crit Rev Eukaryot Gene Expr 12:237-257
14. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Ume-sono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
15. Moggs JG, Orphanides G 2001 Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep 2:775-781
16. Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Book-out AL, Mangelsdorf DJ, Evans RM 2005 A nuclear receptor atlas: macrophage activation. Mol Endocrinol 19:2466-2477
17. Lonard DM, O'Malley BW 2005 Expanding functional diversity of the coactivators. Trends Biochem Sci 30:126-132
18. Tremblay GB, Giguère V 2002 Coregulators of estrogen receptor action. Crit Rev Eukaryot Gene Expr 12:1-22
19. Lee JS, Kim KI, Baek SH 2008 Nuclear receptors and coregulators in inflammation and cancer. Cancer Lett 267:189-196
20. Carlberg C, Seuter S 2010 Dynamics of nuclear receptor target gene regulation. Chromosoma 119:479-484
21. Kim SW, Park K, Kwak E, Choi E, Lee S, Ham J, Kang H, Kim JM, Hwang SY, Kong YY, Lee K, Lee JW 2003 Activating signal cointe-grator 2 required for liver lipid metabolism mediated by liver X receptors in mice. Mol Cell Biol 23:3583-3592
22. Kim GH, Park K, Yeom SY, Lee KJ, Kim G, Ko J, Rhee DK, Kim YH, Lee HK, Kim HW, Oh GT, Lee KU, Lee JW, Kim SW 2009 Characterization of ASC-2 as an antiatherogenic transcriptional coactivator of liver X receptors in macrophages. Mol Endocrinol 23:966-974
23. Bannister AJ, Schneider R, Kouzarides T 2002 Histone methyl-ation: dynamic or static? Cell 109:801-806
24. Hess JL 2004 MLL: a histone methyltransferase disrupted in leukemia. Trends Mol Med 10:500-507
25. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL, Allis CD, Roeder RG 2006 Regulation of MLL1 H3K4 methyltrans-ferase activity by its core components. Nat Struct Mol Biol 13:713-719
26. Steward MM, Lee JS, O'Donovan A, Wyatt M, Bernstein BE, Shilatifard A 2006 Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 13:852-854
27. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Ki-tabayashi I, Herr W, ClearyML 2004 Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24:5639-5649
28. Mishra BP, Ansari KI, Mandal SS 2009 Dynamic association of MLL1, H3K4 trimethylation with chromatin and Hox gene expression during the cell cycle. FEBS J 276:1629-1640
29. Ansari KI, Kasiri S, Mandal SS 27 August 2012 Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo. Oncogene 10.1038/onc.2012.352
30. Ansari KI, Kasiri S, Mishra BP, Mandal SS 2012 Mixed lineage leukaemia-4 regulates cell-cycle progression and cell viability and its depletion suppresses growth of xenografted tumour in vivo. Br J Cancer 107:315-324
31. Ansari KI, Hussain I, Shrestha B, Kasiri S, Mandal SS 2011 HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment. J Mol Biol 411:334-349
32. Ansari KI, Shrestha B, Hussain I, Kasiri S, Mandal SS 2011 Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression. Biochemistry 50:3517-3527
33. Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT 2006 Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 66:4929-4935
34. Lee S, Lee DK, Dou Y, Lee J, Lee B, Kwak E, Kong YY, Lee SK, Roeder RG, Lee JW 2006 Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc Natl Acad Sci USA 103:15392-15397
35. Mo R, Rao SM, Zhu YJ 2006 Identification of the MLL2 complex as a coactivator for estrogen receptor a. J Biol Chem 281:15714-15720
36. Ansari KI, Hussain I, Kasiri S, Mandal SS 2012 HOXC10 is over-expressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. J Mol Endocrinol 48:61-75
37. Bogaard HJ, Mizuno S, Hussaini AA, Toldo S, Abbate A, Kraskaus-kas D, Kasper M, Natarajan R, Voelkel NF 2011 Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med 183:1402-1410
38. Hamamori Y, Schneider MD 2003 HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy. J Clin Invest 112:824-826
39. Rai M, Soragni E, Jenssen K, Burnett R, Herman D, Coppola G, Geschwind DH, Gottesfeld JM, Pandolfo M 2008 HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One 3:e1958
40. Wadsack C, Hrzenjak A, Hammer A, Hirschmugl B, Levak-Frank S, Desoye G, Sattler W, Malle E 2003 Trophoblast-like human choriocarcinoma cells serve as a suitable in vitro model for selective cholesteryl ester uptake from high density lipoproteins. Eur J Biochem 270:451-462
41. Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, Awasthi S 2007 Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 67:4382-4389
42. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, Renthal W, Graham A, Birnbaum SG, Green TA, Robison B, Lesselyong A, Perrotti LI, Bolaños CA, Kumar A, Clark MS, Neumaier JF, Neve RL, Bhakar AL, Barker PA, Nestler EJ 2009 Nuclear factor kB signaling regulates neuronal morphology and cocaine reward. J Neurosci 29:3529-3537
43. Liu D, Bachmann KA 1998 An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats. J Pharmacol Exp Ther 286:561-568
44. Sudhir K, Komesaroff PA 1999 Clinical review 110: Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab 84: 3411-3415
45. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
46. Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ 1994 Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men. J Clin Endocrinol Metab 78:855-861
47. Shono N, Kumagai S, Higaki Y, Nishizumi M, Sasaki H 1996 The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and glucose metabolism in healthy men. J Atheroscler Thromb 3:45-51
48. Eacker SM, Agrawal N, Qian K, Dichek HL, Gong EY, Lee K, Braun RE 2008 Hormonal regulation of testicular steroid and cholesterol homeostasis. Mol Endocrinol 22:623-635
49. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J 2001 Requirement of Sp1 and estrogen receptor a interaction in 17β-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142:1546-1553
50. Lopez D, Sanchez MD, Shea-Eaton W, McLean MP 2002 Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A. Endocrinology 143:2155-2168
51. Lindholm J, Winkel P, Brodthagen U, Gyntelberg F 1982 Coronary risk factors and plasma sex hormones. Am J Med 73:648-651
52. Semmens J, Rouse I, Beilin LJ, Masarei JR 1983 Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women. Metabolism 32: 428-432
53. Ansari KI, Mandal SS 2010 Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J 277: 1790-1804
54. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor co-regulators: cellular and molecular biology. Endocr Rev 20:321-344
55. Hermanson O, Glass CK, Rosenfeld MG 2002 Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13:55-60
56. Mandal SS, Chu C, Wada T, Handa H, Shatkin AJ, Reinberg D 2004 Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II. Proc Natl Acad Sci USA 101:7572-7577
57. Sims 3rd RJ, Mandal SS, Reinberg D 2004 Recent highlights of RNA-polymerase-II-mediated transcription. Curr Opin Cell Biol 16:263-271
58. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L 1996 Nuclear receptor coactivators and corepressors. Mol Endo-crinol 10:1167-1177